Is Growth Priced into Amgen Stock after Earnings Beat?

Amgen Inc. NASDAQ: AMGN delivered a solid earnings report after the market closed on August 3. Shareholders hope the results will be enough to reverse the fortunes of AMGN stock, down 12% in 2023. But heading into earnings, analyst sentiment suggests that all the growth may already be priced into…#amgeninc #amgn #amgen #abbvieinc #abbv #humira #amjevita #fda #evenity #repatha

Source: Reuters: Health - August 7, 2023 Category: Consumer Health News Source Type: news